Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial

CONTEXT: Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and efficacy have not been compared. OBJECTIVE: To test whether allogeneic MSCs are as safe and effective as au...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA
Prif Awduron: Hare, Joshua M., Fishman, Joel E., Gerstenblith, Gary, DiFede Velazquez, Darcy L., Zambrano, Juan P., Suncion, Viky Y., Tracy, Melissa, Ghersin, Eduard, Johnston, Peter V., Brinker, Jeffrey A., Breton, Elayne, Davis-Sproul, Janice, Schulman, Ivonne H., Byrnes, John, Mendizabal, Adam M., Lowery, Maureen H., Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, Ruiz, Phillip, Amador, Alexandra, Silva, Jose Da, McNiece, Ian K., Heldman, Alan W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762261/
https://ncbi.nlm.nih.gov/pubmed/23117550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2012.25321
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg